	US 11,793,845 B2
	Composition for ameliorating peripheral sensory neuropathy
Shozo Nishida, Osaka (JP); Masanobu Tsubaki, Osaka (JP); Tomoya Takeda, Osaka (JP); Kiyotaka Okuno, Osaka (JP); and Satoshi Wachi, Osaka (JP)
Assigned to KINKI UNIVERSITY, Osaka (JP); and KOBAYASHI PHARMACEUTICAL CO., LTD., Osaka (JP)
Filed by KINKI UNIVERSITY, Osaka (JP); and KOBAYASHI PHARMACEUTICAL CO., LTD., Osaka (JP)
Filed on May 24, 2021, as Appl. No. 17/328,401.
Application 17/328,401 is a division of application No. 16/470,811, abandoned, previously published as PCT/JP2017/045547, filed on Dec. 19, 2017.
Claims priority of application No. 2016-247143 (JP), filed on Dec. 20, 2016.
Prior Publication US 2021/0275616 A1, Sep. 9, 2021
Int. Cl. A61K 36/07 (2006.01); A61P 25/02 (2006.01); A61P 35/00 (2006.01); A61K 33/243 (2019.01); A61K 9/00 (2006.01); A61K 31/337 (2006.01); A61K 31/381 (2006.01); A61K 31/4748 (2006.01); A61K 31/4965 (2006.01)

CPC A61K 36/07 (2013.01) [A61K 9/0056 (2013.01); A61K 31/337 (2013.01); A61K 31/381 (2013.01); A61K 31/4748 (2013.01); A61K 31/4965 (2013.01); A61K 33/243 (2019.01); A61P 25/02 (2018.01); A61P 35/00 (2018.01)]

8 Claims

1. A method of ameliorating peripheral sensory neuropathy, comprising:

administering a composition including a Lentinus edodes mycelium extract to a patient having peripheral sensory neuropathy, thereby ameliorating the peripheral sensory neuropathy, wherein the peripheral sensory neuropathy is induced after administration of an anticancer drug.